Vimarsana
Biggest News Aggregation in the World

Page 3 - Purchase Additional News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Purchase Additional. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Purchase Additional Today - Breaking & Trending Today

Investegate |Centessa Pharmaceuticals plc Announcements | Centessa Pharmaceuticals plc: Centessa Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional ADSs - Vimarsana News

Investegate |Centessa Pharmaceuticals plc Announcements | Centessa Pharmaceuticals plc: Centessa Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional ADSs

Investegate announcements from Centessa Pharmaceuticals plc, Centessa Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional ADSs

Eloxx Pharmaceuticals : Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares (Form 8-K) - Vimarsana News

Eloxx Pharmaceuticals : Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares (Form 8-K)

Message : Required fields Eloxx Pharmaceuticals, Inc. Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares WALTHAM, Mass., May 18, 2021 (GLOBE NEWSWIRE) - Eloxx Pharmaceuticals, Inc. (the 'Company') (Nasdaq: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today announced the closing of an underwritten public offering of 38,333,334 shares of common stock at a public offering price of $1.35 per share. The closing included the full exercise of the underwriters' option to purchase an...

Vivos Therapeutics : Announces Closing of Follow-On Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares (Form 8-K) - Vimarsana News

Vivos Therapeutics : Announces Closing of Follow-On Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares (Form 8-K)

Message : Required fields Vivos Therapeutics Announces Closing of Follow-On Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares HIGHLANDS RANCH, Colo., May 11, 2021 - Vivos Therapeutics, Inc. (Nasdaq: VVOS) ('Vivos'), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (OSA), today announced the closing of its underwritten follow-on public offering of 4,600,000 shares of its common stock. The offering cons...

FACT SHEET: President Biden to Take Action to Advance Racial Equity and Support Underserved Communities - Vimarsana News

FACT SHEET: President Biden to Take Action to Advance Racial Equity and Support Underserved Communities

Administration to Purchase Additional 200 Million Doses to Be Delivered This Summer This afternoon, President Biden will outline his vision and new elements of his agenda for advancing racial equity for Americans who have been underserved and left behind. Equal opportunity is the fundamental promise of America. But systemic racism and discrimination in our economy, laws, and institutions have put the promise of America out of reach for too many families of color.   President Biden will renew the federal government’s commitment to making the American Dream real for families across the natio...

Fact Sheet: President Biden Announces New Steps to Boost Vaccine Supply and Increase Transparency for States, Tribes, and Territories - Vimarsana News

Fact Sheet: President Biden Announces New Steps to Boost Vaccine Supply and Increase Transparency for States, Tribes, and Territories

Administration to Purchase Additional 200 Million Doses to Be Delivered This Summer Just over a year since the first COVID-19 case was confirmed in the United States, the nation has hit another grim milestone in the pandemic, reaching 25 million infections and counting. The pace in which this virus has spread throughout the U.S. is staggering and with new variants emerging, the spread is not slowing any time soon. That’s why it is critical that we vaccinate as many people as possible, as quickly as possible. President Biden has a comprehensive National Action Strategy to put the pandemic be...